A phase I study of bevacizumab (BV) plus ABT-510 in patients with advanced solid tumors
Publication
, Conference
Uronis, HE; Bendell, J; Blobe, G; Morse, M; Geier, D; Nixon, A; Howard, L; Evans, D; Li, H; Hurwitz, H
Published in: JOURNAL OF CLINICAL ONCOLOGY
June 20, 2007
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
June 20, 2007
Volume
25
Issue
18
Publisher
AMER SOC CLINICAL ONCOLOGY
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Uronis, H. E., Bendell, J., Blobe, G., Morse, M., Geier, D., Nixon, A., … Hurwitz, H. (2007). A phase I study of bevacizumab (BV) plus ABT-510 in patients with advanced solid tumors. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 25). AMER SOC CLINICAL ONCOLOGY.
Uronis, H. E., J. Bendell, G. Blobe, M. Morse, D. Geier, A. Nixon, L. Howard, D. Evans, H. Li, and H. Hurwitz. “A phase I study of bevacizumab (BV) plus ABT-510 in patients with advanced solid tumors.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 25. AMER SOC CLINICAL ONCOLOGY, 2007.
Uronis HE, Bendell J, Blobe G, Morse M, Geier D, Nixon A, et al. A phase I study of bevacizumab (BV) plus ABT-510 in patients with advanced solid tumors. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2007.
Uronis, H. E., et al. “A phase I study of bevacizumab (BV) plus ABT-510 in patients with advanced solid tumors.” JOURNAL OF CLINICAL ONCOLOGY, vol. 25, no. 18, AMER SOC CLINICAL ONCOLOGY, 2007.
Uronis HE, Bendell J, Blobe G, Morse M, Geier D, Nixon A, Howard L, Evans D, Li H, Hurwitz H. A phase I study of bevacizumab (BV) plus ABT-510 in patients with advanced solid tumors. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2007.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
June 20, 2007
Volume
25
Issue
18
Publisher
AMER SOC CLINICAL ONCOLOGY
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences